These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37630842)

  • 1. Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study.
    Jurczewska J; Ostrowska J; Chełchowska M; Panczyk M; Rudnicka E; Kucharski M; Smolarczyk R; Szostak-Węgierek D
    Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical Activity, Rather Than Diet, Is Linked to Lower Insulin Resistance in PCOS Women-A Case-Control Study.
    Jurczewska J; Ostrowska J; Chełchowska M; Panczyk M; Rudnicka E; Kucharski M; Smolarczyk R; Szostak-Węgierek D
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.
    Chen L; Xu WM; Zhang D
    Fertil Steril; 2014 Oct; 102(4):1167-1174.e4. PubMed ID: 25064406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of C-reactive protein, adiponectin and leptin in the association between abdominal adiposity and insulin resistance in middle-aged individuals.
    Noordam R; Boersma V; Verkouter I; le Cessie S; Christen T; Lamb HJ; Rosendaal FR; Willems van Dijk K; van Heemst D; de Mutsert R
    Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1306-1314. PubMed ID: 32507340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
    Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
    Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
    de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
    Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome.
    Tao T; Li S; Zhao A; Zhang Y; Liu W
    Eur J Endocrinol; 2012 Nov; 167(5):705-13. PubMed ID: 22945299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.
    Frederiksen L; Nielsen TL; Wraae K; Hagen C; Frystyk J; Flyvbjerg A; Brixen K; Andersen M
    J Clin Endocrinol Metab; 2009 Oct; 94(10):4010-5. PubMed ID: 19755479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 12. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
    Wang H; Cao H; Cao J; Zhang L
    Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Changes in Body Composition in Obese Patients with Polycystic Ovary Syndrome after Laparoscopic Sleeve Gastrectomy:a 12-Month Follow-up.
    Cai M; Gao J; Du L; Cheng X; Zhou D; Zhu J; Qu S; Zhang M
    Obes Surg; 2021 Sep; 31(9):4055-4063. PubMed ID: 34152560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients?
    Albu A; Florea S; Fica S
    Endocrine; 2016 Jan; 51(1):163-73. PubMed ID: 26067083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
    Kort DH; Kostolias A; Sullivan C; Lobo RA
    Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
    Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R
    Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.